Skip to main content
Clinical Trials/ISRCTN51398568
ISRCTN51398568CompletedNot Applicable

Prophylactic infusion of CD4 positive donor lymphocytes early after T-cell depleted stem cell transplantatio

eiden University Medical Centre (Netherlands)0 sites60 target enrollmentStarted: June 27, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Both males and females
  • 2. Age from 18 to 70 years
  • 3. Patients with acute myeloid leukaemia (AML), myelodysplasia (MDS), acute lymphocytic leukaemia (ALL), chronic myeloid leukaemia (CML) in accelerated phase or blastic transformation, chronic lymphocytic leukaemia (CLL), multiple myeloma (MM) or aggressive lymphoma, who received an allogeneic stem cell transplantation.

Exclusion Criteria

  • 1. Systemic immunosuppressive treatment
  • 2. Progressive Graft Versus Host Disease (GVHD)
  • 3. GVHD of the skin greater than grade 2
  • 4. Progressive disease needing cytoreductive treatment

Investigators

Sponsor
eiden University Medical Centre (Netherlands)

Similar Trials

Prophylactic infusion of CD4 positive... | Clinical Trial